pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. “There isn’t a one-size-fits-all for how the life sciences industry creates content.

Life Science 97

Life Science Compliance Production Pharma Companies 97

Pharmaceutical Technology

OCTOBER 28, 2022

While implemented to improve transparency and market competition, this new legislation has caused considerable upheaval for clinical trial providers. But if they’re doing that internally, they may have a bias, either because of a life sciences background or involvement in the clinical trial itself.

Clinical Trials 130

Clinical Trials Clinical Trials Life Science Trials 130

XTalks

JANUARY 15, 2024

Decentralized Clinical Trials (DCTs) Gaining Momentum Visiongain’s 2023 report estimates that the market size for DCTs was approximately $7.67 RWE is being used to understand treatment effects in broader, more diverse populations and in post-marketing surveillance to monitor the long-term effects of approved treatments.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

XTalks

MAY 3, 2024

Healthcare company Real Chemistry announced its introduction of IRIS, an insights-as-a-service platform that will deliver all things related to GLP-1 drugs. This includes news on the obesity market, the latest info on current and future GLP-1 drugs and the overall growing influence of GLP-1 therapies.

Drugs 52

Drugs Clinical Trials Clinical Trials Marketing 52

XTalks

NOVEMBER 9, 2023

XTALKS WEBINAR: Impacts of the New IVD Regulation (IVDR) for Manufacturers and Users Live and On-Demand: Tuesday, January 9, 2024, at 10am EST (4pm CET/EU-Central) Register for this free webinar to learn about the specific compliance requirements, risk assessments and quality management changes mandated by the IVDR.

FDA Approval 64

FDA Approval HR Genotype Life Science 64

Drug Discovery World

JANUARY 5, 2023

Frits Stulp and Aida Demneri , partners at Deloitte (including Iperion – a Deloitte business), outline how life sciences companies can play their part in driving change. In the past two years, EU regulatory authorities accelerated processes so that vaccines and medicines could be brought to market more quickly.

Life Science 52

Life Science Production Medicine Compliance 52

XTalks

JANUARY 11, 2021

Companies outsource to gain access to specialized expertise and technology, scale pharmacovigilance (PV) activities, and reduce costs. However, the efficiency and effectiveness of externalized safety activities are below expectations for many biotech and pharma companies.

Pharma Companies 90

Pharma Companies Compliance Clinical Outsourcing Regulation 90

VirTrial

JANUARY 10, 2020

The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharma companies. The company was selected for its industry leading Virtual Care Management (VCM) program. To learn more about VirTrial, visit [link].

Clinical Trials 97

Clinical Trials Clinical Trials Clinical Research Pharma Companies 97

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. He takes us through the challenges of a successful launch and explains what pre-commercial companies need to focus on to hit their goals. Building strong data foundations. ” says Hale.

Production 52

Production Sales Life Science Marketing 52

Drug Discovery World

AUGUST 10, 2023

In this article, Amplexor asks some of the company’s closest industry partners and BE THE EXPERT event speakers for their views on the biggest developments in the Life Sciences Regulatory sphere over the last 12 months – and explore some of the most prominent themes and priorities seen throughout 2023.

Production 98

Production Life Science Development Manufacturing 98

XTalks

MAY 6, 2022

They discussed current challenges and solutions that life science companies and clinical development organizations have with the management of clinical data. To produce ethical results in a timely manner, life science companies should ensure that they have a robust and reliable clinical data pipeline in place.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

OCTOBER 3, 2022

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses. About the author.

Branding 116

Branding Doctors Doctor Compliance 116

pharmaphorum

NOVEMBER 25, 2021

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. Rethinking pharma’s events’ strategy. Creating HCP events that leave lasting impressions.

Pharma Companies 98

Pharma Companies Production Sales Marketing 98

pharmaphorum

FEBRUARY 11, 2022

It’s our representation of tracking the deidentified, which is important from a privacy and compliance point of view,” Sun says. “It During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health. About the author.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

MAY 27, 2022

The possibilities are endless, and in the context of trial participation and access to medicine technologies could assist: Reduced assessment times and hence increased patient compliance. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next?

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

JUNE 10, 2022

Pharma’s evolving role in patient care. The digital revolution has already reshaped the commercial engine of biopharma companies. However, pharma’s commercial leaders are uniquely positioned to drive the strategic digital shift in patient care journeys. Digital can help ensure that their drugs have the biggest clinical impact.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

pharmaphorum

MARCH 18, 2021

A way to ensure compliance is to make sure the voice is not recorded but analysed and the full text is purged in real-time, leaving only the summarised call notes. Pharma companies and sales reps need to adapt to their customer behaviours to stay relevant”. This can overcome any privacy concerns. But it doesn’t stop there.

Sales 52

Sales Pharma Companies Engineer Life Science 52

Drug Discovery World

APRIL 3, 2023

I quickly recognised the commercial value of aptamers as being able to address the gap in the market where antibodies fail to perform, and together we established the business to begin aptamer development. DS: The company now has clients across big pharma. To what do you attribute your success?

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. It’s been eventful 12-month period for the UK biotech guru Clive Dix, who has just seen his company C4X Discovery clinch a major inflammatory diseases deal with Sanofi.

Vaccination 98

Vaccination Vaccine Life Science Antibody 98